SAM
RVMD icon

Shell Asset Management’s Revolution Medicines RVMD Stock Holding History

Shell Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$25K Sell
544
-889
-62% -$34.8K ﹤0.01% 1007
2025
Q2 		$53K Sell
1,433
-152
-10% -$5.84K ﹤0.01% 1137
2025
Q1 		$56K Sell
1,585
-66
-4% -$2.68K ﹤0.01% 1132
2024
Q4 		$72K Buy
1,651
+81
+5% +$4.09K ﹤0.01% 1114
2024
Q3 		$71K Buy
+1,570
New +$68.4K ﹤0.01% 1122
2024
Q1 		$65K Sell
1,663
-208
-11% -$6.17K ﹤0.01% 1114
2023
Q4 		$54K Buy
+1,871
New +$45K ﹤0.01% 1165

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Shell Asset Management's RVMD Position: Q3 2025 in Review

Shell Asset Management reduced its Revolution Medicines (RVMD) stake by 62% in Q3 2025, selling an estimated $34.8K and leaving 544 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

Shell Asset Management first reported a position in RVMD in Q4 2023 and has held it in 7 quarters since. The position peaked at $72K in Q4 2024. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Shell Asset Management held 544 shares of Revolution Medicines worth $25K as of Q3 2025.
  • Shell Asset Management sold 889 Revolution Medicines shares in Q3 2025, an estimated $34.8K.
  • Revolution Medicines made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1007 holding.
  • Shell Asset Management first reported a position in Revolution Medicines in Q4 2023 and has held it in 7 quarters since.
  • Shell Asset Management's Revolution Medicines position peaked at $72K in Q4 2024.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.